A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

INTRODUCTION: Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), approved for treatment of type 2 diabetes mellitus (T2DM). There is limited direct evidence comparing the efficacy and tolerability of exenatide 2 mg once weekly (QW) to other GLP-1 RAs. A network meta-analysis (NMA) w...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Ther
主要な著者: Kayaniyil, Sheena, Lozano-Ortega, Greta, Bennett, Heather A., Johnsson, Kristina, Shaunik, Alka, Grandy, Susan, Kartman, Bernt
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2016
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801811/
https://ncbi.nlm.nih.gov/pubmed/26886440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0155-1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料